UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 26, 2023

Accession Number:	0001214659-23-008639
Submission Type:	POS AM
CIK: 0001643918 Company Name: Biodexa Pharmaceuticals Plc File Number: 333-240984